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Department of Biochemistry, Cambridge Centre for Proteomics, University of Cambridge, Cambridge, United
Kingdom
The structure of N-linked glycans is determined by a complex, anabolic, intracellular pathway
but the exact role of individual glycans is not always clear. Characterization of carbohydrates
attached to glycoproteins is essential to aid understanding of this complex area of biology.
Specific mass spectral detection of glycopeptides from protein digests may be achieved by
on-line HPLC-MS, with selected ion monitoring (SIM) for diagnostic product ions generated
by cone voltage fragmentation, or by precursor ion scanning for terminal saccharide product
ions, which can yield the same information more rapidly. When glycosylation is heteroge-
neous, however, these approaches can result in spectra that are complex and poorly resolved.
We have developed methodology, based around precursor ion scanning for ions of high m/z,
that allows site specific detection and structural characterization of glycans at high sensitivity
and resolution. These methods have been developed using the standard glycoprotein, fetuin,
and subsequently applied to the analysis of the N-linked glycans attached to the scrapie-
associated prion protein, PrPSc. These glycans are highly heterogeneous and over 30 structures
have been identified and characterized site specifically. Product ion spectra have been
obtained on many glycopeptides confirming structure assignments. The glycans are highly
fucosylated and carry Lewis X or sialyl Lewis X epitopes and the structures are in-line with
previous results. [Abbreviations: Hex–Hexose, C6H12O6 carbohydrates, including mannnose
and galactose; HexNAc—N-acetylhexosamine, C8H15NO6 carbohydrates, including N-acetyl-
glucosamine and N-acetylgalactosamine; GlcNAc—N-acetylglucosamine; GalNAc—N-acetyl-
galactosamine; Fuc–Fucose; NeuAC—N-acetylneuraminic acid or sialic acid; TSE—Transmis-
sible Spongiform Encephalopathy.] (J Am Soc Mass Spectrom 2002, 13, 1065–1077) © 2002
American Society for Mass Spectrometry
One of the major challenges for mass spectro-metry in the post-genomic era is the qualitativeand quantitative characterization of post-trans-
lational modifications of proteins. A plethora of biolog-
ically relevant modifications exists, characterized by
small changes in mass, for example deamidation of
asparagine or glutamine residues or disulphide bond
formation, to larger changes in mass, for example
phosphorylation of serine, threonine, or tyrosine resi-
dues or N-glycosylation of specific asparagine residues.
Post-translational modifications are of vital importance
since they frequently determine, or are involved in,
protein structure, function, ligand binding, protein–
protein interactions or regulation of function. Thus, the
detection and characterization of a protein’s post-trans-
lational modifications could be considered at least as
important as the confirmation of identity of the protein
itself.
Amongst cell-surface proteins, the most ubiquitous
modification is glycosylation. Typically, carbohydrates
can be linked to proteins via the oxygen atoms of serine
or threonine side chains (O-linked glycosylation) or to
the nitrogen atom of asparagine side chains (N-linked
glycosylation). Asparagine residues appearing in the
consensus sequence Asn-Xxx-Ser/Thr may be modified
co-translationally in the endoplasmic reticulum (ER) by
the addition of large “core” oligosaccharides. These
structures are then trimmed and modified by a variety
of enzymes as the protein is transported through the ER
and the golgi, potentially resulting in a highly hetero-
geneous population of carbohydrates [1, 2]. Such carbo-
hydrates have been implicated in a wide range of
functions, from aiding protein folding [1] to mediating
cell–cell signalling [3], but a detailed understanding of
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the function of individual carbohydrates remains elu-
sive. It is therefore vital to characterize all carbohy-
drates attached to a glycoprotein to aid understanding
of the role of these structures in normal cell biology. It
is also important to detect changes in glycan structure
during pathogenesis of various diseases since perturba-
tions in the biochemistry of the cell can have profound
effects on the products of the glycosylation pathway. In a
number of disorders, glycosylation on certain proteins is
specifically altered and is indicative of that disease [4–9].
Under electrospray ionization conditions, the use of
high cone voltages, to promote “in-source” fragmenta-
tion of ions, in conjunction with selected ion monitoring
(SIM) experiments, allows the specific detection of
glycopeptides from proteolytic digests separated by
on-line HPLC [10]. Frequently used diagnostic frag-
ment ions for SIM experiments are m/z 204 (HexNAc),
274 ([NeuAc-H2O]
), 292 (NeuAc), or 366 (Hex-Hex-
NAc). When unseparated peptide or glycopeptide
mixtures are analyzed by electrospray or nanospray
MS, precursor ion scans for one or more of these
daughter ions in a tandem mass spectrometer specifi-
cally identifies glycopeptides [11, 12]. Precursor ion
scans of heterogeneous glycopeptide mixtures, how-
ever, can yield complex spectra where peaks are often
incompletely resolved. The level of complexity in-
creases when more than one site of N-linked glycosyl-
ation is present within a protein.
Since carbohydrates are typically composed of only a
limited number of types of monosaccharide, and all
N-linked carbohydrates share the same core structure of
two GlcNAcs attached to trimannose (Figure 1), an
accurate mass measurement can often give a good
indication of carbohydrate composition. In order to
characterize fully the structure of the carbohydrates, the
use of MS/MS experiments or exo-glycosidase diges-
tion is considered essential [10, 13, 14]. We present an
alternative strategy for highly sensitive and rapid anal-
ysis of heterogeneous glycopeptide mixtures based on
precursor ion scanning for high m/z ions, which yields
not only high resolution spectra but also provides
structural characterization of the carbohydrate moieties.
The method also allows carbohydrates to be character-
ized site specifically, even if a mixture of glycosylation
sites is present in the same mixture. Our strategy has
been developed using the standard glycopeptide fetuin,
and has then been applied to the analysis of the
N-linked glycans of hamster PrPSc, the scrapie-associ-
ated prion protein, which carries up to 60 different
glycoforms attached to two different sites [14, 15].
The prion protein is the key protein in the transmis-
sible spongiform encephalopathies (TSEs), a family of
diseases including bovine spongiform encephalopathy
(BSE) and Creutzfeldt-Jakob disease (CJD), where the
protein accumulates in large, insoluble aggregates. So-
dium dodecylsulfate polyacrylamide gel electrophore-
sis (SDS-PAGE) analysis of PrPSc extracted from animal
brains suggests that occupancy levels of the two glyco-
sylation sites can vary depending on the strain of TSE.
It is not known, however, whether individual glycan
structures also differ between strains, or whether rela-
tive proportions of each structure are similar. Charac-
terization of the carbohydrates attached to PrPSc is
therefore essential to understand fully the role that this
protein plays in pathogenesis of these fatal, neurode-
generative diseases. Previous work in this area has
focused on the characterization of carbohydrates at-
tached to murine PrPSc from a single TSE strain [14] or
on the differences in carbohydrate structures between
PrPSc and PrPC, the normal, cellular isoform [15]. Our
novel methodology has been developed to provide a
rapid method of mapping carbohydrate structure pro-
files without lengthy labeling or digestion steps and
should enable the identification of any structures spe-
cific to individual TSE strains.
Experimental
Protein Digestion and Purification
Fetuin from fetal calf serum was obtained from Sigma
and was used without further purification. PrPSc was
purified from the brains of scrapie-infected hamsters by
detergent lysis and differential centrifugation according
to the protocol of Hope et al. [16]. Proteins were
dissolved in 6 M guanidinium HCl, reduced and alky-
lated by dithiothreitol and 4-vinyl pyridine respectively
before being precipitated by the addition of 20 volumes
of ice cold ethanol. Proteins were redissolved in 2 M
urea, 100 mM ammonium bicarbonate, pH 8.0, and
were digested by the addition of approximately 5%
(w/w) trypsin (Sigma, Dorset, UK). Tryptic peptides
from both proteins were desalted by binding the pep-
tide mixture onto a C18 ZipTip (Millipore, Bedford, MA)
and step eluting with 0.1% (vol/vol) trifluroacetic acid
or 0.05% formic acid in 50:50 acetonitrile:water accord-
ing to the manufacturers instructions. Where necessary,
glycopeptides from the digest mixture were separated
Figure 1. Structural features of a complex type Asn-linked
glycan typical to neural tissue. Key to structures: Filled square
GlcNAc, open square galactose, open circle mannose, zero NeuAc,
filled inverted triangle fucose.
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on a semi-preparative HPLC column (2.1 mm i.d., 15 cm
length, 3.5 m bead size, 150 Å pore size, Hichrom, Ltd,
Berkshire, UK). The eluent was monitored by passing
approximately 1% of the flow through a Z-view UV
flow cell (LC Packings, Amsterdam, The Netherlands),
to the mass spectrometer whilst the remaining 99% was
collected in fractions.
Mass Spectrometry
Mass spectrometry was by use of either a Quattro II
tandem quadrupole instrument (Micromass UK Ltd.,
Manchester, UK) or a hydrid quadrupole-time of flight
instrument (Q-ToF, Micromass) both equipped with
commercial Z-spray sources. Desalted glycopeptide
fractions (peptide concentration estimated to be 5–10
pmole/l) were loaded in 1 l aliquots into borosilicate
capillaries that had been pulled (Sutter puller Model
753, Campden Instruments Ltd., Leicestershire, UK)
and platinum coated using a sputter coater (Polaron
SEM coating unit E5100, Quorum Technologies, East
Sussex, UK) in-house or gold-coated borosilicate capil-
laries (Micromass). Approximately 1 kV was applied to
the spraying capillary resulting in spraying flow rates
of around 20 nl/min. The Quattro II was used for MS1
scans (m/z 300–2200, 5 s per scan, at least 10 scans
summed) for precursor ion scans (m/z 400–2200, 20 s
per scan, at least 100 scans summed) and for some
product ion scanning (m/z 50–2300, 20 s per scan, at
least 50 scans summed). Typical collisional activation
conditions were around 3.5 mbar of Argon and a
collision energy of 25–40 V. The Q-TOF instrument was
used for product ion scans of low abundance glycopep-
tides under similar fragmentation conditions.
For monitoring PrPSc tryptic peptide HPLC separa-
tion, a continuous flow nanospray source was used on the
Quattro II instrument. 20 m fused silica capillary was
used as the spraying capillary and a voltage of 2.8 kV was
applied. The instrument was scanned from m/z 500–2500,
4 s per scan, and selected ion monitoring was used for m/z
204, 274, 292, and 366 (0.5 s dwell time per ion).
Results and Discussion
When a glycoprotein contains multiple glycosylation
sites, or where glycan structures are very heteroge-
neous, precursor ion scanning for ions fragmenting to
give terminal or internal saccharide ions can detect all
glycopeptides in a digest mixture [11]. Confirming the
identity of the peptide moiety and determining the
structure of the carbohydrate are essential and gener-
ally require a multifaceted approach. This can involve
product ion scans of individual glycopeptide ions
and/or peptide separation and various steps of exogly-
Figure 2. MS of tryptic digest of fetuin. (a) MS1 scan, peptides are labeled with amino acid residue
numbers; (b) precursor ion scan for m/z204, the immonium ion of HexNAc, indicating ions of
glycopeptides from all glycosylation sites. Glycopeptides visible in the MS1 scan are arrowed. (b inset)
Magnification of m/z 204 scan showing sodium adducts on glycopeptide ions.
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cosidase digestion followed by repeat analyses, proce-
dures that can be both time and sample consuming [13,
17]. Under normal CAD conditions, glycopeptides frag-
ment predominately within the carbohydrate moiety
producing Y- and B-type fragment ions (nomenclature
as Domon and Costello [18]). Since Y1 (or Y1, Y1) ions
(peptide plus the reducing terminal GlcNAc) will have
the same mass for all glycopeptides that have the same
peptide moiety, such ions can be used as diagnostic
fragment ions. Thus, we believed that precursor ion
scans for ions that fragment to give a particular Y1 ion
could selectively detect glycopeptides from a common
glycosylation site. We have tested this hypothesis using
an unseparated tryptic digest of fetuin, a 37 kDa protein
that has three sites of N-linked glycosylation (Asn 81,
Asn 138, Asn 158) and various sites of O-linked glyco-
sylation (Ser 253, Thr 262, Ser 264). The glycans are
heterogeneous and this protein therefore provides a
good substrate for development of the methodology,
not least because the carbohydrates attached have pre-
viously been well characterized.
Fetuin Glycan Characterization
A tryptic digest of fetuin from fetal calf serum was
desalted using a Zip-Tip (Millipore), eluted with 50%
(vol/vol) acetonitrile with 0.05% (vol/vol) formic acid
and the peptide pool analyzed by nanospray-MS. The
mass spectrum of this mixture is shown in Figure 2a,
from which various tryptic peptides can be identified
by comparison to a theoretical digest from the protein
sequence. These are labeled in Figure 2a with the
residue numbers. By comparison to known fetuin gly-
cosylation, a number of putative glycopeptides could
also be identified [10]. A precursor ion scan at m/z 204
(HexNAc) selectively detected glycopeptides from the
tryptic peptide mixture and is shown in Figure 2b. The
spectrum includes peaks from a range of glycopeptides,
many of which, although of low intensity, can be
observed in the standard mass spectrum. The majority
of the glycopeptide peaks also have associated peaks
caused by sodium adduction, the relevance of which
will become clear later. The precursor ion spectrum has
signals from all glycosylation sites (N-linked and O-
linked) contained within the protein and, at each site,
the carbohydrate structures are heterogeneous. This
2-fold heterogeneity accounts for the complexity of the
spectrum, and also indicates the necessity to character-
ize each glycopeptide fully.
The most abundant glycopeptide ion, at m/z 1176,
was chosen for product ion scanning and the CAD mass
spectrum of this ion is shown in Figure 3. The spectrum
contains predominately high m/z Y type fragment ions
as well as small, low m/z B ions (this part of the
spectrum is not shown) indicative of fragmentation
within the carbohydrate. The peptide portion of the ion
does not appear to fragment at all. The doubly charged
Y type fragment ions reveal the sequence of the pen-
tasaccharide core of the carbohydrate (shown in Figure
1), but other fragment ions also allow some outer arm
structures to be elucidated. The Y1
2 ion, at m/z 1020
(peptide and the reducing terminal GlcNAc) is the most
abundant Y-type fragment ion in the spectrum and this
ion confirms the identity of the peptide portion of the
glycopeptide and thus the site of glycosylation, in this
case Asn 138 (for peptide sequences and masses see
figure legends). Enzymatic removal of the glycan chain
with PNG'ase confirmed this assignment by measuring
Figure 3. Product ion scan (m/z 800–2000) of the trisialylated tri-antennary on the Leu 127-Arg 141
peptide (sequence LBPDBPLLAPLNDSR where B  vinyl pyridine cysteine; peptide mass 1837.2 Da)
showing carbohydrate core structures common to all glycopeptides at this site. Only the doubly
charged ion series is labeled. For fragmentation nomenclature see Figure 4.
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the mass of the resultant peptide (data not shown). The
Y1
2 ion and the four other Y ions shown are common
fragment ions for all N-linked glycopeptides at this site.
Thus, precursor ion scanning for any of these ions will
selectively detect glycopeptides that have the same
peptide portion whilst not detecting glycopeptides
from other glycosylation sites.
Using identical fragmentation conditions, a precur-
sor ion scan was used to detect all ions that fragmented
to give the Y1
2 ion (peptide  HexNAc)2 at m/z 1020.
The resulting spectrum is shown in Figure 5a and has
signals corresponding to six different glycopeptides, all
of which share the same peptide sequence, but which
differ in the carbohydrate structure. The inherent sen-
sitivity of this mode of scanning allows the resolution of
the instrument to be increased, leading to better resolved
peaks. The level of background noise from which the
glycopeptides are detected is evident from the peak at m/z
1020, which represents chemical noise passed at the frag-
ment ion m/z without fragmentation. The glycopeptides
are detected well above the noise level for this spectrum
and it is interesting to note that the efficiency of detection
of sodiated glycopeptides is dramatically reduced in this
spectrum, compared to both the standard MS1 and m/z
204 precursor ion scan, the rationale for which will be
discussed later in the PrP section. This enables a more
equivocal measure of the mass of the glycopeptide and
allows carbohydrate compositions to be assigned unam-
biguously. The glycopeptides represent six structures,
some of which have been detected previously at the Asn
138 site. These structures are listed in Table 1. An addi-
tional ion was also observed at m/z 878, the mass of which
did not correspond to a possible glycopeptide ion. CAD of
this ion demonstrated that this is the N-terminal tryptic
peptide spanning the first 32 residues of fetuin and the
product ion spectrum included a weak z ion of m/z 1020,
rationalizing its appearance in the m/z 1020 precursor ion
scan.
Characterization of the Asn 138 site enables these
peptides to be identified in the initial precursor ion scan
for m/z 204, and hence also allowed the identification of
glycopeptides from other sites. Sequentially, other gly-
copeptides were selected for CAD analysis, which again
revealed common Y ions for precursor ion scanning and
allowed specific detection of glycopeptides from one of
the other N-linked sites (Asn 81, Figure 5b), and the
glycopeptides including the O-linked sites (Figure 5c).
In each case, the Y1
2 fragment ions, (peptide  Hex-
NAc), were chosen for precursor ion scanning since
they were typically the most abundant Y-type fragment
ions. This approach will work for all N-linked sites,
since the reducing terminal sugar is always N-acetyl-
glucosamine (GlcNAc). The O-linked glycans detected
in this case all have N-acetylgalactosamine (GalNAc) at
their reducing termini, which is an epimer of GlcNAc
and therefore has the same mass.
Glycopeptides from the remaining N-linked glyco-
sylation site, Asn 158, gave low intensity signals in both
the MS1 scan and the precursor ion scan for m/z 204.
Additionally, potential Y ions for scanning coincided
with stronger signals from other sites making analysis
of glycopeptides from this site problematic without
prior concentration/purification. The tryptic digest was
partially fractionated by HPLC, and redissolved in 50%
(vol/vol) acetonitrile and 0.05% (vol/vol) trifluoroace-
tic acid to promote the formation of higher m/z ions. A
lower charge state Y1 fragment ion was chosen for
precursor ion scanning and this resulted in a good
precursor ion scan, the quality of which was compara-
ble to that of the other sites. The precursor ion mass
spectrum for site Asn 158 is shown in Figure 5d.
Glycopeptides detected at this site were more heteroge-
neous than previously detected and this may have
contributed to the detection problems encountered. The
increased heterogeneity could be the product of sample
degradation or of cone voltage mediated dissociation,
but the lack of these effects at the other sites suggests
that these results are not artefactual.
The full range of carbohydrates detected on fetuin by
this novel methodology is shown in Table 1. Although
slightly more heterogeneous, they agree well with pre-
viously published data [10, 19, 20]. The N-linked struc-
tures have up to three antennae and up to four sialic
acid moieties. In the trianntennary, tetrasialylated spe-
cies one sialic acid appears to be 2–6 linked to N-
acetylglucosamine rather than the more common 2–6
linkage to galactose. This linkage cannot be ruled out in
the other structures, and may be present in the sialy-
lated Structure g (Hex3HexNAc3NeuAc1), the composi-
tion of which (confirmed by product ion scanning)
suggests a structure without any galactose. Alterna-
tively, the trimannosyl core may not be intact, and a
single galactose-containing arm may be sialylated in the
more common manner. It is difficult to resolve this by
low energy CAD experiments since galactose and man-
nose have the same mass. O-linked glycosylation on the
peptide spanning Val 228–Arg 288 is reported as car-
bohydrate compositions and is again slightly more
heterogeneous than previously published MS data [10].
Figure 4. Fragmentation nomenclature of a glycopeptide (only
carbohydrate moiety shown) as Domon and Costello [Domon B,
1988 no. 87]. Y type fragmentation ions always include the intact
peptide. Key to structures: Filled square GlcNAc, open square
galactose, open circle mannose, filled inverted triangle fucose.
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No attempt was made to elucidate the structure of these
carbohydrates.
Prion Protein (PrPSc)
The prion protein, PrP is a cell membrane bound
glycoprotein of approximately 210 amino acids and an
unmodified mass of around 23 kDa. Post translational
modifications include two Asn-linked glycosylation
sites [14, 15], a GPI anchor [21], a single disulphide
bond [22], and partial proline hydroxylation near the
N-terminus [23]. The glycosylation of the prion protein
has been suggested to play a fundamental role in the
transmissible spongiform encephalopathies (TSEs) [24–
26]. Crucially occupancy of the 2 N-linked glycosylation
sites varies depending on the strain of TSE disease [27]
and blockade of glycosylation of PrP can promote
scrapie-like pathogenesis in cultured cells [24]. Differ-
ences in the structures of individual carbohydrates have
also been observed between the normal, PrPC, and
diseased PrPSc isoforms of the protein [15]. Although
there were no gross differences in carbohydrate struc-
tures, PrPSc had fewer saccharides containing bisecting
GlcNAc moieties, consistent with down regulation of
the saccharide transferase enzyme GnT III during dis-
ease pathogenesis. A method for rapid and sensitive
elucidation of these carbohydrate structures and com-
parison of glycopeptide profiles is of paramount impor-
tance for future work in this area. Although the N-
linked carbohydrates at the two sites on PrP are more
heterogeneous than those of fetuin [3, 14, 15, 28], our
precursor ion scanning methodology should be appli-
cable. Glycans from rodent neural tissues may carry the
bisecting GlcNAc motif, fucosylation at the reducing
terminal GlcNAc (core), and outer arm GlcNAcs (Lewis
X epitope) are typical [29, 30], although sialylation is not
as common as in fetuin. These features are shown in
Figure 1 and the structural complexity necessitates
Figure 5. Fetuin glycopeptides detected by precursor ion scanning of an unseparated peptide
mixture, unless otherwise noted. All scans are at the mass/charge of an ion for the glycosylation site
peptide  HexNAc. Glycan structure on the peptide is indicated in the table below. (a) Precursors of
m/z 1020.70 (2); a scan for glycosylation on the L127-R141 peptide (sequence LBPDBPLLAPLNDSR
where B vinyl pyridyl cysteine; aglycosyl peptide mass 1837.2 Da). (b) Precursors of m/z 993.60 (4);
a scan for glycosylation on the R54-R85 peptide (sequence RPTGEVYDIEIDTLETTBHVLDPTPLAN-
BSVR where B  vinyl pyridyl cysteine; aglycosyl peptide mass 3769.3 Da). (c) Precursors of m/z
1254.20 (6); a scan for O-linked glycosylation on the V228-R288 peptide (peptide mass 6066.0 Da). (d)
Precursors of m/z 1610.50 (2); a scan for glycosylation on the V142-R169 peptide (sequence
VVHAVEVALATFNAESNGSYLQLVEISR; aglycosyl peptide mass 3017.4 Da) on a HPLC separated
fraction. The peak labeled “noise” in each case is at the mass/charge of the precursor ion, and
represents the non-specific passing of chemical background noise at that mass/charge ratio.
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considerably more characterization than is the case with
fetuin glycans; structure-specific precursor ion scans
may be used to aid characterization.
Specific Detection of Glycosylation at the Asn 181
Site
Purified PrP was reduced, alkylated and digested with
trypsin. The peptide pool was desalted by use of a
Zip-Tip and an MS 1 scan of this (Figure 6a) includes a
variety of peaks corresponding to tryptic peptides. Due
to the heterogeneity of the glycoforms, the abundance
of any glycopeptide ion will be low relative to the more
intense peptide signals, hence peaks corresponding to
glycopeptide ions are not obvious in the MS1 scan. A
glycosylation specific precursor ion scan for HexNAc at
m/z 204 (Figure 6b) reveals all glycopeptides from the
two sites (Asn 181 and Asn 197). From this scan the
heterogeneity of glycosylation is evident.
As with the fetuin, a high m/z fragment ion from a
glycopeptide is required for specific detection of glyco-
sylation at a given site and is derived from CAD of a
selected glycopeptide. A product ion scan on the most
abundant glycopeptide ion (m/z 1406), showed many
fragment ions including a dominant doubly charged Y
ion series (Figure 7a). The Y1, Y1 ion for [peptide 
GlcNAc]2, a fragment ion specific to all glycosylated
forms of this peptide (the designation Y1, Y1 assumes
core fucosylation of the glycan) is evident. This data
also revealed that the carbohydrate was attached to the
157–185 peptide (for peptide sequences and masses see
figure legends), an observation that was confirmed by
measuring the mass of peptide released after enzymatic
deglycosylation with PNG'ase. The composition of this
Table 1a. N-linked glycans detected on fetuin by precursor ion
scanning
Label
Glycan
structurea
L127-R141
peptide
(a)
R54-R85
peptide
(b)
V142-R169
peptide
(d)
A   
B   
C  
D   
E 
F  
G   
H 
I 
J 
aKey to structures:  GlcNAc,  Galactose, O Mannose, 0 NeuAc.
Table 1b. O-linked glycans detected on fetuin by precursor ion
scanning
Label Composition
L Hex3HexNAc3NeuAC4
M Hex3HexNAc3NeuAC3
N Hex2HexNAc2NeuAC2
O Hex2HexNAc2NeuAC3
P Hex1HexNAc1NeuAC1
Table 2. Structure of carbohydrates on Y ions from Figure 7
Label Fragment Ion Composition
Structure of
glycana,b
A Y1, Y1 HexNAc
B Y1 HexNAcFuc
C Y2, Y1 HexNAc2
D Y2 HexNAc2Fuc
Ed Y3, Y3 (Y3) HexHexNAc2Fuc
F Y3x, Y4x, Y1 Hex2HexNAc2
(Y3)
G Y3, Y3, Y1 HexHexNAc3
H Y3x, Y4x, (Y3) Hex2HexNAc2Fuc
Ic Y4, Y4, Y1,
(Y3)
Hex3HexNAc2
J Y3, Y3 HexHexNAc3Fuc
K ? Hex2HexNAc3 Indeterminable
e
Lc Y4, Y4 (Y3) Hex3HexNAc2Fuc
M ? Hex2HexNac3Fuc Indeterminable
e
aFor key to glycopeptide fragmentation nomenclature see Figure 4.
Peptide is the Tyr 157-Lys185 peptide (mass  3665.06).
bKey to structures:  GlcNAc,  galactose, E mannose, ’ fucose.
cFragment ions I and L are not designated as Y3 cleavage as they are
thought to be products of structures not containing bisecting GlcNAc.
dWith fragment ion E, the parent ion is undetermined hence the
occurrence of the Y3 cleavage is also undetermined.
eStructures labeled as indeterminable could be one of several possible
structures for the given composition.
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glycan was found to be that of the most abundant
glycan identified by two previous studies [14, 15].
The (Y1, Y1)
2 ion at m/z 1935 was used in a site
specific precursor ion scan to detect all Asn 181 glyco-
peptides (Figure 6c). By comparison with Figure 6b, it
can be seen that the majority of ions detected in the m/z
204 scan appear to result from glycopeptides at the 181
site. As expected, the more specific m/z 1935 scan was of
markedly increased quality compared with the m/z 204
scan. The sensitivity of the m/z 1935 precursor ion scan
is illustrated by the comparison to the noise peak at m/z
1935, suggesting that glycopeptides were present at
levels of low fmole/l. Despite the better quality spec-
trum, however, improvements in terms of signal to
noise ratio and resolution were still desirable. The PrPSc
tryptic peptides were separated by HPLC and fractions
containing the glycopeptides were collected. Figure 6d
shows an MS1 scan of the fraction containing the Asn
181 site glycopeptides. Co-purifying, non-glycosylated
peptides are still evident, and two peptides from the N
terminus (residues 49–106, theoretical mass 5872.2 Da;
residues 38–106, theoretical mass 6943.3 Da) are prom-
inent. An m/z 204 precursor ion scan (Figure 6e) con-
firmed the major glycopeptide ion at this site to be m/z
1406 (4) and an m/z 1935 precursor ion scan (Figure 6f)
again produced a spectrum superior in quality to the
m/z 204 B ion scan.
The high m/z Y1, Y1 precursor ion scans consis-
tently have better signal to noise ratios and improved
resolution over the low m/z B ion scans. This may be
because higher m/z ions are less common from a frag-
mentation so are less likely to be the product of an
interfering non-glycopeptide molecule, whereas low
m/z precursor ion scans tend to include more interfer-
ence from non-glycopeptide ions. In addition, in B ion
precursor ion scans, where a glycopeptide has a cation
adducted (most typically sodium ions), both the glyco-
peptide and the equivalent adduct ions are detected
(see Figure 2), presumably because the cation attaches
via the peptide moiety. With Y1 ion precursor scans,
adduction on the peptide will produce adducted Y1 ions
of increased mass, which will not be detected in a Y1 ion
precursor ion scan. This will decrease peak width when
using lower MS1 resolution necessary for the detection
of weak signals, hence aid glycopeptide identification
during precursor ion scanning. This is illustrated with
the fetuin data, when adducted species detected in the
MS1 and m/z 204 precursor scans are not seen in the Y1
precursor ion scan.
Characterization of Glycans at the Asn 181 Site
Ions detected in the Y1, Y1 precursor ion scans were
used to obtain masses of the glycopeptides and, by
subtraction of the peptide mass, masses of the glycans
present at this site. These measurements were then
related to the glycan composition, and are shown in
Table 3. Elucidation of the branching structure of the
glycan, which cannot always be determined by compo-
sition alone, is dependent upon the detection of a
Figure 6. Mass spectra of PrPSc tryptic digest, desalted by Zip-Tip (a,b,c) or partially purified HPLC
fraction containing the Asn 181 site (d,e,f). (a) and (d) MS1 scans. (b) and (e) precursor ion scan at m/z
204 for the immonium ion of HexNAc. (c) and (f) precursor scan at m/z 1934.5 for the Y1 ion of the
Asn181 peptide  HexNAc (sequence YPNQVYYRPVDQYNNQNNFVHDBVNITIK; aglycosyl pep-
tide mass 3665.1 Da). Note that only the most intense glycopeptide ion [1406 (4)] is visible on only
the MS1 of the HPLC fraction. Also, the level of the m/z 1935 noise peak is well above many of the
detected glycopeptides. Selected m/z are labeled.
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bisecting GlcNAc (GlcNAc to the core mannose) (see
Figure 1). In some cases the carbohydrate composition
will indicate that a bisecting GlcNAc is not possible,
e.g., where the number of hexoses exceed the number
the number of HexNAcs by one. In these cases the
antennae are fully galactosylated, and no GlcNAcs are
left over to be attached to the mannose by a 1–4
linkage. In other cases (where the number of hexoses is
less than or equal to the number of HexNAcs) the
structure is not clear. The presence of bisecting GlcNAc
has previously been shown to be relevant in PrPSc. In a
comparative study of the glycoforms of the normal and
diseased forms of the protein, it was observed that the
diseased form possessed decreased levels of glycans
containing bisecting GlcNAcs [15].
The product ion scan of the m/z 1406 ion, shown
previously to contain bisecting GlcNAc [14, 15] in-
cluded an ion resulting from Y3, Y3 fragmentation,
which can be assigned the structure [peptide  Hex-
HexNAc3]
2. This ion, at m/z 2219, is the product of Y
type fragmentation across mannose™mannose 1–6 and
1–3 bonds (i.e, loss of both branches) leaving the 1–4
linked bisecting GlcNAc intact. It is diagnostic for
bisecting GlcNAc structure and common to all glycans
that carry this motif attached to the 157–185 glycopep-
tide, therefore precursor ion scanning for this ion will
detect glycopeptide ions containing bisecting GlcNAc.
The possibility exists, however, of isomeric glycopep-
tides either having or not having bisecting GlcNAc. The
product ion scan of a non-bisected glycopeptide of mass
5580.4 Da (Figure7b) suggested that the fragment ion
[peptide  Hex3HexNAc2]
2 (Y4, Y4)
2 was an ion
exclusive to non-bisecting glycopeptides and precursor
ion scanning for this ion would detect glycopeptide ions
not having bisecting GlcNAc. Observations from previ-
ously published data help to support this. In studies on
the fragmentation of glycans containing bisecting Glc-
NAc it was seen that: (1) The Y ion series of loss of outer
arm GlcNAcs ends before the loss of the final GlcNAc
[31] and (2) the outer mannose moieties will dissociate
in preference to the bisecting GlcNAc [32]. From this it
would appear that the Y type fragment ion of peptide
Hex2HexNAc3 is unlikely to arise from CID of glyco-
peptides with bisecting GlcNAcs.
The two doubly charged ions at m/z 2280 and 2219
were used for precursor ion scanning for structural
characterization of glycopeptides. These scans are
shown in Figure 8. An additional scan at m/z 1480 (for
[peptide  HexNAc3 Hex]
3) was used to confirm the
presence of bisecting GlcNAc (not shown). It is imme-
diately apparent that more ions appear in the m/z 2280
(no bisecting GlcNAc) scan, indicating a greater number
of structures without the bisecting GlcNAc motif. Some
ions are unique to one scan indicating homogeneity of
structure for a glycopeptide (e.g., masses 5580.4 and
5766.6 Da). Some ions appear in both scans, indicating
two isomeric structures for a single glycopeptide ion
(e.g., glycopeptides of mass 5621.7 and 5313.3 Da). As
with the m/z 1935 precursor ion scan, the strongest peak
is at m/z 1406, and the majority of strong signals are
from the ions carrying four positive charges. With
reference to Figure 7, it is evident that the structural
fragment ions being scanned for are of weaker intensity
than the Y1, Y1 ions used for initial glycopeptide
detection. This reduces the intensity of the structural
precursor ion scans compared to the Y1 precursor scan
and necessitates the use of lower resolution to increase
sensitivity, hence these scans do not give accurate mass
data, but are only indicative of ions in the Y1 scan.
To provide additional information on outer arm
structures, precursor ion scans for B ions indicative of
the Lewis X epitope ([HexHexNAcFucH]m/z 512)
and sialic acid (m/z 274/292) may be used. These will
largely resolve glycopeptides that are close in mass in
cases when the composition is not clear. The B ion scan
at m/z 512 for Asn181 glycopeptides containing the
Lewis X epitope is shown in Figure 9. This spectrum has
broad peaks and suffers from the lack of resolution
encountered with B ion scanning, hence is used only as
an indication of the presence of the Lewis X epitope.
From this data it was possible to resolve multiply
fucosylated species from sialylated species in instances
where no more than three fucoses or one sialic acid
were present. With a larger number of potential moi-
Figure 7. Q-TOF product ion scans of PrPSc Asn181 glycopeptide
ions. Doubly charged Y ion series labeled only. For ion identity see
Table 3. Ions indicative of structural characteristics are labeled in
bold large font; G m/z 2219 (2) indicative of bisecting GlcNAc, I
m/z 2280 (2) indicative of structure free of bisecting GlcNAc. (a)
Parent ion at m/z 1406, a glycopeptide ion heterogeneous in
bisecting GlcNAc structure. (b) Parent ion at m/z 1396, a glyco-
peptide ion for a structure with no bisecting GlcNAc present.
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Table 3. Glycopeptides from PrPSc detected and characterised by precursor ion scanning
Ionsa
Precursor ion scansb Mass of glycopeptide Compositiong
Structure(s)h
m/z
2219
m/z
2280
m/z
512 Measured Calculated Hex HexNAc Fuc NeuAc
1278.4 (4) c  Xd 5109.80 5110.42 3 4 1 0
1704.4 (3)
1319.2 (4)   X 5271.93 5272.56 4 4 1 0
1758.1 (3)
1063.4 (5)   X 5313.26 5313.62 3 5 1 0
1329.4 (4)
1772.3 (3)
1084.6 (5)    5418.13 5418.70 4 4 2 0
1355.4 (4)
1807.1 (3)
1359.6 (4) X  X 5433.90 5434.7 5 4 1 0
1088.0 (5)
1096.3 (5)   X 5475.74 5475.76 4 5 1 0
1369.9 (4)
1826.4 (3)
1117.1 (5) X   5580.40 5580.84 5 4 2 0
1396.1 (4)
1125.4 (5)    5621.72 5621.90 4 5 2 0
1406.3 (4)
1874.6 (3)
1146.2 (5) X  X 5725.92 5725.96 5 4 1 1
1432.5 (4)
1154.2 (5) X   5766.55 5768.04 4 5 3 0
1442.8 (4)
1158.27 (5) X  Qe 5785.10 5783.02 5 5 0 1
1447.0 (4) 5784.04 5 5 2 0
979.7 (6)    5872.03 5866.16#f 3 7 2 0
1175.6 (5)
1468.8 (4) 5872.10 5 4 2 1
1958.4 (3)
1183.0 (5)   Q 5912.16 5913.16 4 5 2 1
1479.5 (4)
1187.1 (5)  X  5929.13 5930.18 5 5 3 0
1483.2 (4)
1977.5 (3)
1194.8 (5)  X Q 5969.26 5970.22 4 6 1 1
1493.4 (4) 5971.24 4 6 3 0
1216.1 (5)  X  6076.14 6075.30 5 5 2 1
1520.2 (4)
1020.2 (6)   X 6133.64 6132.36 5 6 1 1
1227.8 (5)
1534.5 (4
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eties, resolution could not be achieved by this method
alone, but an additional precursor ion scan for sialic
acid can resolve these problems. Although sialic acid
often gives intense B ions (m/z 274/292) from product
ion scanning, attempts to precursor ion scan at m/z 274
resulted in poorly resolved spectra (not shown). This is
not due to the nature of the scan itself, since a similar
scan on the fetuin glycopeptides produced similar re-
sults to the m/z 204 scan. It may be, in part, due to the
heterogeneity of the sialylated species present and the
low amounts of sample, bringing the signal below the
detection limit.
Once data from each of the precursor ion scans have
been analyzed and collated, it can be trivial to deter-
mine the structures of the saccharides. For example,
from the Y1 precursor ion scan a glycopeptide of mass
5766.6 Da could be detected. Subtraction of the mass of
the peptide leaves a mass of 2101.5 Da for the carbohy-
drate implying a composition of Hex4HexNAc5Fuc3.
The 4 ion of this glycopeptide (m/z 1442.8) appears in
the precursor ion scan for the absence of bisecting
GlcNAc, but not in the precursor ion scan for the
presence of this motif, implying a single structural
isomer without bisecting GlcNAc. Having determined
the saccharide core, this leaves three HexNAc moeities
(hence tri-antennary), two fucoses, and an additional
hexose. The 5 ion of this glycopeptide (m/z 1154.2)
appears in the Lewis X scan and from this information
the outer arm structures may all be defined.
Figure 8. Structural precursor ion scans on the Asn 181 glyco-
sylation site of the prion protein. (a) Scan at m/z 2280 for the 4, 4
fragment ion (2 ion for peptide  Hex3HexNAc2) indicative of
the absence of bisecting GlcNAc. (b) Scan at m/z 2219 for the 3, 3
fragment ion (2 ion for peptide  HexHexNAc3), indicative of
the presence of GlcNAc  1–4 to the core mannose (bisecting
GlcNAc).
Figure 9. Precursor ion scan at m/z 512 for PrPSc glycopeptide
structures from the Asn 181 site carrying the Lewis X epitope.
Table 3. Continued
Ionsa
Precursor ion scansb Mass of glycopeptide Compositiong
Structure(s)h
m/z
2219
m/z
2280
m/z
512 Measured Calculated Hex HexNAc Fuc NeuAc
1047.5 (6)  X  6277.54 6277.48 5 6 2 1
1256.6 (5)
1569.9 (4)
1268.4 (5) X  Q 6336.79 6335.56 5 7 1 1
1585.1 (4)
6336.58 5 7 3 0
1278.08 (5) X   6384.21 6383.68 6 5 3 1
1596.77 (4)
1639.2 (4) X  Q 6533.43 6554.78 4 6 5 1
2185.8 (3)
1318.43 (5)    6588.91 6586.78 6 6 3 1
1648.68 (4)
aIons refer to the m/z and charge (in parentheses) of detected species derived from Figures 6 c  f.
bPrecursor ion scans are at the m/z indicated: m/z 2219 for the presence of bisecting GlcNAc, m/z 2280 for the absence of bisecting GlcNAc, and relate
data from Figures 8 a  b. The scan at m/z 512 is for the presence of Lewis X, as shown in Figure 9.
c Indicates presence of an ion. or
dX Absence of an ion in the respective scan.
eQ Indicates that CAD on a Q-TOF instrument was required for full characterization of a given feature.
fThe discrepancy in mass shown here is discussed in the text.
gComposition relates to the composition of the glycan moiety based on measured mass.
hStructure is the structure of the glycan moiety concluded from the precursor ion scans.
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In some cases, however, structures are more prob-
lematic; structural scans need to be analyzed more
closely and structures can be extrapolated from knowl-
edge of glycobiology. For example, in the case of the
glycopeptide of measured mass 6076.14 Da, three pos-
sible structures were considered: One afucosyl and disia-
lylated, one difucosylated and monosialylated, and one
asialyl with tetrafucosylation (i.e., three outer arms fuco-
ses). Precursor ion ruled out both the afucosyl (as Lewis X
was present) and tetrafucosylated structure (as with a
bisecting GlcNAc the structure would be biantennary,
hence unable to support that degree of fucosylation).
The m/z 2219 and 2280 scans for presence or absence
of bisecting GlcNAc may also help to resolve unrelated
structures that are close in mass. For instance, the ion
with m/z 1175 ion appears in both the m/z 2219 and the
2280 scans, implying two structures, one with a bisect-
ing GlcNAc and the other without. The measured mass
indicates a digalactosylated bianntennary, with no
spare HexNAc moieties for a bisecting GlcNAc (hence a
non-bisecting structure). The only other possible struc-
ture that could have bisecting GlcNAc is the glycopep-
tide corresponding to an ion at m/z 1174.23, an agalac-
tosyl tetraantennary. These ions are not resolvable by
this instrument under these conditions, but can be
resolved by the structural precursor ion scans.
The carbohydrate structures deduced from this work
are shown in Table 3. Product ion scans were used to
determine the presence or absence of NeuAc when the
possibility of sialylation required further investigation.
In the case of particularly weak ions, undetected by the
structural precursor ion scans, product ion scans were
done by use of a Q-ToF instrument. In rare cases
(glycopeptides of mass 5912.2 and 5785.1 Da) product
ion scanning was required to accurately characterize the
structure of the glycopeptide. Many confirmatory prod-
uct ion scans were also conducted on established struc-
tures. Saccharides are presented as determined core
structures, with determined outer arm structures.
Where only one possibility of outer arm connectivity
exists, structures are shown without ambiguity. The
inclusion of brackets (Table 3) is to indicate that linkage
information has not been generated and thus outer arm
structures could have various different linkages. Al-
though linkage information is required to completely
characterize the structures of individual carbohydrates,
relatively few techniques exist that can reliably provide
this information. The elucidation of core and outer arm
structures, as well as the presence/absence of bisecting
GlcNAc moieties, however, represents a major advance
from carbohydrate compositional information.
Structures detected and characterized encompass a
range of structures from bisected monoantennaries up
to non-bisected pentaantennaries, almost all fucosylated
and a significant proportion carrying the Lewis X epitope.
Sialylation is also common but not widespread. Out of the
35 structures identified, around half have been previously
characterized in hamster 263k scrapie. The proposed gly-
copeptides are often structural isomers of previously iden-
tified glycans, low in abundance, and usually detected as
a consequence of bisect/non-bisect precursor ion scan-
ning. This may be as a product of a small amount of
bisected glycans forming the 4, 4, 3 fragment ion, which
had not been previously observed in product ion scans.
Alternatively these may have been minor components
that were not detected in other MS studies, which were
not designed to detect structural isomerism.
Asn 197 Site
PNG'ase removal of the glycan chain revealed heteroge-
neity in the glycosylated peptide. As noted in earlier work
[14], cleavage at Lys 194 can be variable, and the N-
terminal glutamine of uncleaved peptide is partly con-
verted to pyro-glutamic acid, resulting in a variety of
different size peptides containing this glycosylation site.
This heterogeneity, in addition to that of the carbohy-
drates themselves, makes analysis more complex. Only
preliminary data has been acquired, but the glycosylation
on each of the three peptides can be evaluated indepen-
dently using three different sets of precursor ion scans.
The glycosylation at this site has been shown to be the
most heterogeneous of the two sites [14] and the increased
variety in glycan structures at this site is immediately ob-
vious from the Y1 precursor ion scan for the shortest of the
three peptides (Figure 10a). Putative compositions can be
determined based on this data, and structures can be tenta-
tively assigned from the accompanying bisect ion scan (Fig-
ure 10b), however no assignments are given here. Full
characterization of this site will appear in a later publication.
Conclusion
In this paper we report a rapid and sensitive method for
glycopeptide detection and characterization. Changes
in glycoform pattern can quickly and easily be deter-
mined, and fine characterization can be done at a later
stage if desired, by complementary methods including
exoglycosidase digestion and product ion scanning. This
Figure 10. Preliminary precursor ion scans for Asn 197 site
glycopeptides. (a) Scan at m/z 1357 for Y1, Y1 fragment ion, 1152
Da peptide  HexNAc. (b) Scan at m/z2074 for the Y3, Y3
fragment ion indicating the presence of a bisecting GlcNAc.
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method requires minimum handling past protein purifi-
cation, so can bypass the need for HPLC purification of
protein digests whilst still giving site specific information.
No derivatization or labeling is required. With an array of
complex glycans, structural data can be obtained for the
pool by precursor ion scanning for fragmentation ions
indicative of certain characteristics. Once glycoform pat-
terns have been established only a rapid glycopeptide
based Y1 precursor ion scan need be applied to an unsepa-
rated protein digest to obtain a glycoform profile.
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